Our analysis revealed that STAT3 was over-expressed in brain and cns, gastric, head and neck, melanoma, myeloma cancers, but was under-expressed in breast, leukemia, liver, lymphoma, and sarcoma cancers as compared to that in normal tissue (Table 1, Figure 2A–2C. The gene discussed is STAT3; the disease is melanoma.